bOPV
Sponsors
University of Chile, Aga Khan University, University of Virginia, PT Bio Farma, Centers for Disease Control and Prevention
Conditions
HealthyOral Polio VaccinePolioPoliomyelitisVaccine Virus Shedding
Phase 3
Phase 4
Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine
NCT01841671
Start: 2013-04-30End: 2014-06-30Target: 570Updated: 2014-05-20
Polio End-game Strategies - Poliovirus Type 2 Challenge Study
CompletedNCT02189811
Start: 2014-09-30End: 2016-05-31Updated: 2016-05-03
Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV
CompletedNCT03310073
Start: 2016-07-31End: 2017-03-31Updated: 2017-11-08
Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study
CompletedNCT03722004
Start: 2018-12-18End: 2019-12-19Updated: 2021-02-21